| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Viani, A Temellini, G Tusini, G M Pacific. Human brain sulphotransferase and glucuronyltransferase. Human & experimental toxicology. vol 9. issue 2. 1990-06-28. PMID:2111157. |
the kinetics of st were studied varying the concentration of 1-naphthol in five brain specimens (temporal cortex, temporal subcortex, occipital cortex, cerebellum cortex and frontal cortex) whereas those of gt were studied in a sample obtained by pooling the microsomal fractions from the following eight brain tissues: one frontal cortex, four temporal cortex, one parietal cortex and two cerebellar cortex specimens. |
1990-06-28 |
2023-08-11 |
human |
| J H Kaas, L A Krubitzer, K L Johanso. Cortical connections of areas 17 (V-I) and 18 (V-II) of squirrels. The Journal of comparative neurology. vol 281. issue 3. 1989-05-18. PMID:2703555. |
injections in area 18 revealed 1) zones of discontinuous connections with area 17 that followed a topographic pattern, 2) patches of intrinsic connections that spread over distances of up to 6-8 mm from the injection site; 3) two zones of uneven connections with ot cortex suggesting the locations of at least two visual areas, otr and otc; 4) connections with limbic cortex rostromedial to areas 17 and 18; 5) sparse connections with regions of temporal cortex lateral to ot; and 6) uneven callosal connections with area 18 and ot cortex. |
1989-05-18 |
2023-08-11 |
Not clear |
| S Jégou, F Javoy-Agid, C Delbende, D Tranchand-Bunel, D H Coy, Y Agid, H Vaudr. Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects. Peptides. vol 9. issue 4. 1989-04-04. PMID:3226955. |
detailed mapping of vip in the human cerebral cortex showed the existence of a rostro-caudal gradient of vip-li concentrations: the frontal cortex exhibited the highest vip levels, the parietal and temporal cortex contained medium values and the occipital cortex contained the lowest vip levels. |
1989-04-04 |
2023-08-11 |
human |
| D M Mann, B Marcyniuk, P O Yates, D Neary, J S Snowde. The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathology and applied neurobiology. vol 14. issue 3. 1988-09-15. PMID:3405392. |
these data show that both the clinical and the pathological progression of alzheimer's disease is marked by a continuing loss of pyramidal cells from frontal and temporal cortex, although the densities of plaques and tangles within the cortex do not, per se, correlate with the stage of the illness. |
1988-09-15 |
2023-08-11 |
Not clear |
| K J Reinikainen, L Paljärvi, T Halonen, O Malminen, V M Kosma, M Laakso, P J Riekkine. Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiology of aging. vol 9. issue 3. 1988-09-08. PMID:3398991. |
dopamine (da) concentrations were decreased significantly in the temporal cortex, hippocampal cortex and hippocampus in ad/sdat patients. |
1988-09-08 |
2023-08-11 |
Not clear |
| H S Mayberg, R G Robinson, D F Wong, R Parikh, P Bolduc, S E Starkstein, T Price, R F Dannals, J M Links, A A Wilso. PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. The American journal of psychiatry. vol 145. issue 8. 1988-08-25. PMID:3394877. |
the ratio of binding in the ipsilateral to contralateral cortex showed a significant negative correlation with severity of depression scores in the left temporal cortex. |
1988-08-25 |
2023-08-11 |
human |
| M Reichman, W Nen, L E Hoki. Acetylcholine releases prostaglandins from brain slices incubated in vitro. Journal of neurochemistry. vol 49. issue 4. 1987-10-19. PMID:3114429. |
under these conditions, 5 mm ach significantly increased the efflux of pge and pgf from brain regions enriched in muscarinic cholinergic receptors, i.e., cerebral cortex, temporal cortex, corpus striatum, and hippocampus. |
1987-10-19 |
2023-08-11 |
Not clear |
| C M Waters, S P Hunt, P Jenner, C D Marsde. Localization of neurotensin receptors in the forebrain of the common marmoset and the effects of treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain research. vol 412. issue 2. 1987-08-28. PMID:3038264. |
in the cerebral cortex neurotensin receptors are concentrated in layers i, ii, iii and v, whilst receptor density is generally less in all layers of middle temporal cortex. |
1987-08-28 |
2023-08-11 |
marmoset |
| S N Deyo, W J Shoemaker, A Ettenberg, F E Bloom, G F Koo. Subcutaneous administration of behaviorally effective doses of arginine vasopressin change brain AVP content only in median eminence. Neuroendocrinology. vol 42. issue 3. 1986-04-03. PMID:3951675. |
the accumulation of [8-arginine]vasopressin (avp) in brain areas inside the blood-brain barrier (thalamus-hypothalamus, amygdala with overlying temporal cortex, hippocampus and cerebral cortex) and outside the blood-brain barrier (median eminence of the hypothalamus and area postrema) was measured after subcutaneous injection of the hormone. |
1986-04-03 |
2023-08-11 |
rat |
| M Hayashi, K Oshim. Neuropeptides in cerebral cortex of macaque monkey (Macaca fuscata fuscata): regional distribution and ontogeny. Brain research. vol 364. issue 2. 1986-04-01. PMID:2418918. |
a high level of somatostatin was found in the association cortex (prefrontal, parietal and temporal cortex); the lowest level was noted in the occipital cortex. |
1986-04-01 |
2023-08-11 |
monkey |
| J M Candy, A D Gascoigne, J A Biggins, A I Smith, R H Perry, E K Perry, J R McDermott, J A Edwardso. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. Journal of the neurological sciences. vol 71. issue 2-3. 1986-03-17. PMID:2868073. |
in cases of senile dementia of alzheimer type (sdat), where abundant neurofibrillary tangles and senile plaques (density greater than 30 per 1.3-mm2 field) were present in the cerebral cortex, somatostatin immunoreactivity was found to be significantly decreased in either the frontal or temporal cortex. |
1986-03-17 |
2023-08-11 |
Not clear |
| C M Yates, G Fink, J G Bennie, A Gordon, J Simpson, R L Eska. Neurotensin immunoreactivity in post-mortem brain is increased in Down's syndrome but not in Alzheimer-type dementia. Journal of the neurological sciences. vol 67. issue 3. 1985-05-29. PMID:3157784. |
the concentrations of neurotensin were significantly increased in the caudate nucleus, temporal cortex and frontal cortex in the cases of down's syndrome aged 53-63 years with the neuropathological features of atd, and were also increased in the cerebral cortex of the 27-year-old, which did not have the neuropathological features of atd, and in two infant down's cases. |
1985-05-29 |
2023-08-11 |
human |
| A S Iontov, F N Makarov, E E Granstrem, V F Shefe. [Special forms of ultrastructural changes in dendrites and axons in the human and cat brain]. Arkhiv anatomii, gistologii i embriologii. vol 87. issue 12. 1985-03-20. PMID:6525057. |
the investigation has been performed in the human brain of persons at the age of 75-87 years, in the auditory cortex of old cats and in bioplates obtained from epileptic foci of the hippocamp and the temporal cortex of 11 patients suffering from temporal epilepsy (at the age of 12-29 years). |
1985-03-20 |
2023-08-12 |
human |
| J Hyttel, K F Overø, J Arn. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology. vol 83. issue 1. 1984-08-07. PMID:6429698. |
no changes were seen in bmax and kd for beta-receptors (3h-dihydroalprenolol) in frontal cortex, occipital + temporal cortex, whole cortex and limbic structures, 5-ht2 receptors (3h-spiroperidol) in frontal and whole cortex, alpha 1-receptors (3h-prazosin) in "rest of brain" and da d-2 receptors (3h-spiroperidol) in corpus striatum and limbic structures. |
1984-08-07 |
2023-08-12 |
rat |
| P van den Bosch de Aguilar, C Langhendries-Wéverberg, J Goemaere-Vanneste, J Flament-Durand, J P Brion, A M Couc. Transplantation of human cortex with Alzheimer's disease into rat occipital cortex; a model for the study of Alzheimer disease. Experientia. vol 40. issue 4. 1984-05-30. PMID:6714374. |
when human temporal cortex with alzheimer's disease is implanted in the occipital cortex of 7-week-old rats, human cerebral tissue containing abundant tangles induces in the receiver cortex a reactive fibrous gliosis. |
1984-05-30 |
2023-08-12 |
human |
| T D Bird, S Stranahan, S M Sumi, M Raskin. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Annals of neurology. vol 14. issue 3. 1983-12-20. PMID:6227276. |
there was a tendency for choline acetyltransferase activity to be lower in cortex from patients with early-onset alzheimer's disease compared with cortex from the late-onset group, and this difference was significant in temporal cortex. |
1983-12-20 |
2023-08-12 |
human |
| S Brion, A Psimaras, J F Chevalier, J Plas, G Massé, O Jattea. [Association of Pick's disease and amyotrophic lateral sclerosis. Pathological study of one case and review of the literature (author's transl)]. L'Encephale. vol 6. issue 3. 1981-03-27. PMID:7449725. |
against the last hypothesis, one could argue that, in "pick's disease + als", there is no superficial spongiosis such as seen generally in als + dementia in frontal or temporal cortex, or in als simplex in motor cortex. |
1981-03-27 |
2023-08-12 |
Not clear |
| M N Rossor, P C Emson, C Q Mountjoy, M Roth, L L Iverse. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neuroscience letters. vol 20. issue 3. 1981-02-24. PMID:6108540. |
a significant fall in choline acetyltransferase (chat) activity was observed in the cortex, hippocampus and amygdala of the sdat cases and was maximal in the temporal cortex. |
1981-02-24 |
2023-08-12 |
Not clear |